DK392786D0 - Farmaceutiske praeparater indeholdende acylerede phospholipider - Google Patents

Farmaceutiske praeparater indeholdende acylerede phospholipider

Info

Publication number: DK392786D0
Authority: DK; Denmark
Prior art keywords: appropriate; pharmaceutically acceptable; phospholipid; alkylene; atoms
Prior art date: 1985-08-19

Application number

DK392786A

Other languages

English (en)

Other versions

DK392786A (da

DK165314C (da

DK165314B (da

Inventor

Alan J Schroit

Rajiv Nayar

Original Assignee

Univ Texas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-08-19

Filing date

1986-08-18

Publication date

1986-08-18

1986-08-18 Application filed by Univ Texas filed Critical Univ Texas

1986-08-18 Publication of DK392786D0 publication Critical patent/DK392786D0/da

1987-02-20 Publication of DK392786A publication Critical patent/DK392786A/da

1992-11-09 Publication of DK165314B publication Critical patent/DK165314B/da

1993-03-29 Application granted granted Critical

1993-03-29 Publication of DK165314C publication Critical patent/DK165314C/da

Links

150000003904 phospholipids Chemical class 0.000 title abstract 3
239000000825 pharmaceutical preparation Substances 0.000 title 1
239000000203 mixture Substances 0.000 abstract 3
125000002252 acyl group Chemical group 0.000 abstract 2
125000004432 carbon atom Chemical group C* 0.000 abstract 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 abstract 1
ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
238000002512 chemotherapy Methods 0.000 abstract 1
235000012000 cholesterol Nutrition 0.000 abstract 1
ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
239000002502 liposome Substances 0.000 abstract 1
230000000144 pharmacologic effect Effects 0.000 abstract 1
150000008105 phosphatidylcholines Chemical class 0.000 abstract 1
150000003905 phosphatidylinositols Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK392786A 1985-08-19 1986-08-18 Farmaceutiske praeparater i form af liposomdispersioner indeholdende acylerede phospholipider, fremgangsmaade til fremstilling deraf samt blandinger til fremstilling af liposomdispersioner DK165314C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US76662585A	1985-08-19	1985-08-19
US76662585		1985-08-19

Publications (4)

Publication Number	Publication Date
DK392786D0 true DK392786D0 (da)	1986-08-18
DK392786A DK392786A (da)	1987-02-20
DK165314B DK165314B (da)	1992-11-09
DK165314C DK165314C (da)	1993-03-29

Family

ID=25077017

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK392786A DK165314C (da)	1985-08-19	1986-08-18	Farmaceutiske praeparater i form af liposomdispersioner indeholdende acylerede phospholipider, fremgangsmaade til fremstilling deraf samt blandinger til fremstilling af liposomdispersioner

Country Status (18)

Country	Link
EP (1)	EP0213523B1 (da)
JP (1)	JPS6296431A (da)
KR (1)	KR870001838A (da)
AT (1)	ATE59002T1 (da)
AU (1)	AU591162B2 (da)
CA (1)	CA1273575A (da)
DD (1)	DD248736A5 (da)
DE (1)	DE3676133D1 (da)
DK (1)	DK165314C (da)
ES (1)	ES2001099A6 (da)
FI (1)	FI863311A (da)
GR (1)	GR862144B (da)
HU (1)	HU206045B (da)
NO (1)	NO171886C (da)
NZ (1)	NZ217239A (da)
PH (1)	PH26160A (da)
PT (1)	PT83204B (da)
ZA (1)	ZA866200B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0256989A1 (en) *	1986-08-18	1988-02-24	Board Of Regents, The University Of Texas System	Pharmaceutical administration systems containing chemotactic peptides
DK86988A (da) *	1987-02-25	1988-08-26	Takeda Chemical Industries Ltd	Liposompraeparat og anvendelse deraf
WO1991014423A1 (en) *	1990-03-20	1991-10-03	Otsuka Pharmaceutical Co., Ltd.	Liposome preparation
DE69429511T2 (de) *	1993-05-21	2002-05-16	The Liposome Co., Inc.	Reduzierung von durch liposome induzierte physiologischen gegenreaktionen
JPH10507450A (ja) *	1994-10-14	1998-07-21	ザリポソームカンパニー、インコーポレーテッド	エーテル脂質リポソームおよびそれらの治療用の使用
US8038984B2 (en)	1998-06-20	2011-10-18	Washington University	Membrane-permeant peptide complexes for treatment of sepsis
US7306784B2 (en)	1998-06-20	2007-12-11	Washington University	Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US6589503B1 (en)	1998-06-20	2003-07-08	Washington University	Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US7803351B2 (en)	2004-08-20	2010-09-28	Washington University	Blood brain barrier permeation peptides
JP2006248978A (ja) *	2005-03-10	2006-09-21	Mebiopharm Co Ltd	新規なリポソーム製剤
EP3676296A1 (en)	2017-08-30	2020-07-08	INSERM (Institut National de la Santé et de la Recherche Médicale)	Anti-mesothelin radiolabelled single domain antibodies suitable for the imaging and treatment of cancers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3218027A1 (de) *	1982-05-13	1983-11-17	A. Nattermann & Cie GmbH, 5000 Köln	Phospholipidloesungen

1986
- 1986-07-18 PH PH34151A patent/PH26160A/en unknown
- 1986-08-14 PT PT83204A patent/PT83204B/pt not_active IP Right Cessation
- 1986-08-15 FI FI863311A patent/FI863311A/fi not_active Application Discontinuation
- 1986-08-15 CA CA000516015A patent/CA1273575A/en not_active Expired - Lifetime
- 1986-08-18 AT AT86111368T patent/ATE59002T1/de not_active IP Right Cessation
- 1986-08-18 NZ NZ217239A patent/NZ217239A/xx unknown
- 1986-08-18 JP JP61191795A patent/JPS6296431A/ja active Pending
- 1986-08-18 GR GR862144A patent/GR862144B/el unknown
- 1986-08-18 HU HU863618A patent/HU206045B/hu not_active IP Right Cessation
- 1986-08-18 EP EP86111368A patent/EP0213523B1/de not_active Expired - Lifetime
- 1986-08-18 KR KR1019860006783A patent/KR870001838A/ko not_active Application Discontinuation
- 1986-08-18 NO NO863315A patent/NO171886C/no unknown
- 1986-08-18 ES ES8601163A patent/ES2001099A6/es not_active Expired
- 1986-08-18 DK DK392786A patent/DK165314C/da not_active IP Right Cessation
- 1986-08-18 DD DD86293707A patent/DD248736A5/de not_active IP Right Cessation
- 1986-08-18 AU AU61556/86A patent/AU591162B2/en not_active Ceased
- 1986-08-18 DE DE8686111368T patent/DE3676133D1/de not_active Expired - Lifetime
- 1986-08-18 ZA ZA866200A patent/ZA866200B/xx unknown

Also Published As

Publication number	Publication date
NO171886B (no)	1993-02-08
DD248736A5 (de)	1987-08-19
JPS6296431A (ja)	1987-05-02
EP0213523A3 (en)	1987-10-14
AU591162B2 (en)	1989-11-30
NZ217239A (en)	1989-09-27
AU6155686A (en)	1987-02-26
EP0213523A2 (de)	1987-03-11
PH26160A (en)	1992-03-18
PT83204A (en)	1986-09-01
HUT41634A (en)	1987-05-28
DK392786A (da)	1987-02-20
ATE59002T1 (de)	1990-12-15
NO863315D0 (no)	1986-08-18
PT83204B (pt)	1989-03-30
CA1273575A (en)	1990-09-04
FI863311A (fi)	1987-02-20
HU206045B (en)	1992-08-28
FI863311A0 (fi)	1986-08-15
DK165314C (da)	1993-03-29
ES2001099A6 (es)	1988-04-16
ZA866200B (en)	1987-03-25
DK165314B (da)	1992-11-09
KR870001838A (ko)	1987-03-28
EP0213523B1 (de)	1990-12-12
NO863315L (no)	1987-02-20
GR862144B (en)	1986-12-23
DE3676133D1 (de)	1991-01-24
NO171886C (no)	1993-05-19

Publication	Publication Date	Title
WO1990004918A3 (en)	1990-08-09	Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
DK392786D0 (da)	1986-08-18	Farmaceutiske praeparater indeholdende acylerede phospholipider
EP0237051A3 (en)	1987-12-02	Prodrug compounds, process for the preparation thereof and sustained release preparation comprising the same
NO178923C (no)	1996-07-03	Analogifremgangsmåte for fremstilling av terapeutisk aktive 24-homo-vitamin-D-derivater
FR2649110B1 (fr)	1994-10-21	Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FI834702A (fi)	1984-07-01	Nya nitroalifatiska foereningar, deras framstaellningsfoerfarande och anvaendning.
IL87254A (en)	1993-01-31	Stable oxapenem- 3-carboxylic acids, their preparation and pharmaceutical compositions containing them
NZ222741A (en)	1990-10-26	Pharmaceutical compositions containing an interferon and a purine derivative
ES8707111A1 (es)	1987-07-16	Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
ES8207538A1 (es)	1982-10-01	Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilicos 6-, 1- y 2-sustituidos.
GB2152508A (en)	1985-08-07	Pyrimidine derivatives
ES2087421T3 (es)	1996-07-16	Acidos (1's)-hidroxialquiloxapenem-3-carboxilicos y su uso como inhibidor de la betalactamasa.
SE8204791D0 (sv)	1982-08-20	Process for preparing alkoxy-vincaminic acid esters and alkoxy-apovincaminic acid esters
PT86422A (fr)	1988-01-01	Procede de preparation de derives d:acide dibenzo]be"-oxepine-acetique et de compositions pharmaceutiques les contenant
RU94042399A (ru)	1996-09-27	Получения клавулановой кислоты из соли клавулановой кислоты и амина, соли клавулановой кислоты и амина

Legal Events

Date	Code	Title	Description
1994-04-25	PBP	Patent lapsed